Lipocine Inc (LPCN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access LPCN Annual Balance Sheets →
The table below presents a historical view of Lipocine Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent4.98
Available-for-sale Securities, Debt Securities, Current MA18.29
Cash & Short-term Investments22.00
Interest Receivable, Current0.10
Other Current Assets0.19
Prepaid Expense And Other Assets Current0.18
Total Current Assets23.74
Equipment/Property/Plant Net0.07
Other Assets, Noncurrent0.02
License Fee And Royalties Receivable Current0.12
Total Assets23.84
Liabilities
Accounts Payable, Current AC0.68
Accrued Liabilities, Current AC1.07
Other Liabilities, Current0.00
Deferred Revenue DE0.32
Total Current Liabilities2.07
Total Long-term Debt0.00
Total Liabilities2.07
Stockholders' Equity
Common Stock Value0.01
Treasury Stock Value-0.04
Additional Paid In Capital Common Stock237.50
Retained Earnings / Accumulated Deficit-215.69
Accumulated Other Comprehensive Income-0.01
Other Equity-0.01
Common Stockholder's Equity21.77
Total Stockholder's Equity21.77
Liabilities & Stockholder's Equity23.84
4 historic quarters locked

Sign in to unlock the full Lipocine Inc balance sheet history.

About Lipocine Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 4, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-035909

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.